Within glioma p53 has a varied role, retaining its wild-type conformation in most primary glioblastomas and acquiring gain-of-function mutations in the pro-neural glioblastoma subtype and during lower-grade glioma progression (Guo et al., 2012; Wanka et al., 2012a). The gene discussed is TP53; the disease is central nervous system cancer.